Events Partner Content Blockchain for Clinical Trials Forum Setting a New Standard for Optimizing Clinical Trials
Views & Analysis Being patient-centric: communication, co-creation and collab... Marco Ricci reports from day two of the eyeforpharma Patient Summit Europe 2017.
Views & Analysis What’s the value of patient centricity? Marco Ricci reports from day one of the eyeforpharma Patient Summit Europe 2017.
Partner Content Partner Content Transforming complex biologics delivery and enhancing patien... Amgen unveil novel drug delivery technologies
Views & Analysis Rare disease market research needs a multifaceted approach Challenges in rare disease market research and the role of online research.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.